Krassimir Mitchev steps up as acting CMO
Calliditas Therapeutics AB (publ) (“Calliditas”) today announced that Dr. Krassimir Mitchev, PhD, will take over the role as Chief Medical Officer (CMO) from December 1, as Jens Kristensen, PhD, has decided to step down for personal reasons. Dr Kristensen will remain a key member of the medical team of the company.Dr Kristensen joined Calliditas in 2016 and has been instrumental in the design of the ongoing Phase 3 study (NefIgArd) and the overall clinical development of Calliditas’ leading compound Nefecon. “I want to thank Jens for the fantastic job he has done for Calliditas as a CMO